About this trial
A preventive, multidisciplinary primary care intervention organized around a therapeutic garden: Acceptability to patients suffering from cardio-neurovascular pathology and to those involved in the action.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age > 18 years old;
living in the vicinity (+-20 km) of Gap, Laragne-Montéglin, Veynes and Clermont-Ferrand;
having been invited to take part in the intervention by the caregivers of the medical structures
suffering from an ALD based on CNAM medical criteria (stroke, AOMI, rhythm disorders, valvular heart disease, congenital heart disease, stage I and II heart failure), severe hypertension, chronic coronary disease)
Disqualifiers
heart failure based on CNAM medical criteria (ALD n°5) stage III and IV according to NYHA classification ;
with a contraindication to physical activity ;
living in an institution;
unable to walk more than 100 m independently;
Trial design
Sequential
Treatments tested in this trial
Intervention of prevention
Other interventionA 6-month multidisciplinary preventive intervention for each patient: gardening, adapted physical activity, nutritional workshops.
Treatment groups
Trial outcomes
Primary outcomes
Acceptance rate of intervention
Assessing the acceptability of a multidisciplinary intervention combining gardening activities, APA and nutrition workshops, organized around a therapeutic garden, by patients suffering from cardio-neurovascular pathologies and the interveners of the action.
Identification of the obstacles and facilitators for intervention
Identify the obstacles and factors facilitating patients' initial adhesion to and commitment to the scheme, and those influencing the implementation of the action by those involved, i.e. the facilitators and caregivers involved.
Secondary outcomes
Assessing the impact of the intervention
Assess the impact of the intervention on quality of life, adoption of new lifestyle habits (PA and Mediterranean diet), depressive symptoms and physical performance, taking into account any adverse effects.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.